Treatment of Brugada Syndrome with an Implantable Cardioverter Defibrillator

The Brugada Syndrome: From Bench to Bedside

Volumn , Issue , 2007, Pages 194-201

  Brugada, Pedro ^a   Bartholomay, Eduardo ^b   Mont, Lluís ^b   Brugada, Ramon ^c   Brugada, Josep ^d  

^a CARDIOVASCULAR CENTER   (Belgium)

^b HOSPITAL CLÍNIC   (Spain)

^c MASONIC MEDICAL RESEARCH LABORATORY   (United States)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cox regression analysis; Implantable cardioverter defibrillator (ICD); Statistical analysis; Sudden arrhythmic death (SAD); Treatment of brugada syndrome

Indexed keywords

EID: 44349131802     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470994900.ch17     Document Type: Chapter

References (18)

1. Priori S, Alliot E, Blomstrom-Lundqvist et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur. Heart J. 2001; 22:1374-1450.
2. Eisenberg MS, Mengert TJ. Primary care: cardiac resuscitation. N. Engl J. Med. 2001; 344; 17.
3. Viskin S, Bellhassen B. Idiopathic ventricular fibrillation. Am.Heart J. 1990; 120:661-671.
4. Brugada P, Brugada J. Right bundle branch block, persistent ST-segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J. Am. Coll. Cardiol. 1992; 20:1391-1396.
5. Chen Q, Kirsch GE, Zhang D et al. Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation. Nature 1998;392:293-296.
6. Brugada J, Brugada R, Brugada P. Right bundle-branch and ST-segment elevation in leads V1 through V3: a marker of sudden death in patients without demonstrable structural heart disease. Circulation 1998; 97:457-460.
7. Antzelevitch C, Brugada P, Brugada J et al. Brugada syndrome: a decade of progress. Circ. Res. 2002;91:114-118.
8. Brugada J, Brugada R, Brugada P. Pharmacological and device approach to therapy of inherited cardiac diseases associated with cardiac arrhythmia and sudden death. J. Electrocardiol. 2000; 33(suppl): 41-47.
9. Kuck, K, Cappato R, Siebels J et al. Randomized comparison of antiarrhythmic drug therapy and implantable defibrillators in patients resuscitated from cardiac arrest (CASH). Circulation 2000; 102:748-754.
10. Connoly S, Gent M, Robin S. Canadian Implantable Defibrillator Study (CIDS). A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302.
11. Nademanee K; Veerakul G, Mower M et al. Defibrillator versus β-blockers for unexplained death in Thailand (DEBUT): a randomized clinical trial. Circulation 2003; 107:2221-2226.
12. Wilde A, Antzelevith C, Borggrefe M et al. Proposed crite-ria of the Brugada syndrome. Eur. Heart J. 2002;23:1648-1654.
13. Nademanee K, Veerakul G, Nimmannit S et al. Arrhyth-mogenic marker for sudden death unexplained death syndrome in Thai men. Circulation 1997; 96:2595-2600.
14. Brugada J, Brugada R, Antzelevitch C et al. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002; 105:73-78.
15. Brugada J, Brugada R, Brugada P. Asymptomatic patients with a Brugada electrocardiogram: are they at risk. J. Cardiovasc. Electrophysiol. 2001;12:0-1.
16. Priori S, Napolitano C, Gasparini M et al. Natural history of Brugada syndrome. Circulation 2002;105:1342-1347.
17. Belhassen B, Viskin S, Fish R et al. Effects of electrophysio-logic-guided therapy with class IA antiarrhythmic drugs on the long term outcome ofpatients with idiopathic ventricular fibrillation with an without the Brugada syndrome. J. Cardiovasc. Electrophysiol. 1999;10: 1301-1312.
18. Brugada P, Geelen P, Brugada R et al. Prognostic value of electrophysiologic investigation in Brugada syndrome. J.Cardiovasc. Electrophysiol. 2001; 12: 1004-1007.